Elevated plasma osteopontin as marker for distant metastases and poor survival in patients with renal cell carcinoma

被引:0
作者
Azizbek Ramankulov
Michael Lein
Glen Kristiansen
Hellmuth-A. Meyer
Stefan A. Loening
Klaus Jung
机构
[1] University Hospital Charité,Department of Urology
[2] Charité—University Medicine Berlin,Institute of Pathology
[3] Campus Charité Mitte,undefined
[4] Charité—University Medicine Berlin,undefined
[5] Campus Charité Mitte,undefined
[6] Republic Center of Urology,undefined
来源
Journal of Cancer Research and Clinical Oncology | 2007年 / 133卷
关键词
Plasma osteopontin; Renal cell carcinoma; Metastases; Tumor marker; Survival analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:643 / 652
页数:9
相关论文
共 192 条
[1]  
Agrawal D(2002)Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling J Natl Cancer Inst 94 513-521
[2]  
Chen T(2005)Plasma osteopontin levels are predictive of disease stage in patients with transitional cell carcinoma of the bladder BJU Int 96 803-805
[3]  
Irby R(2006)Serial plasma osteopontin levels have prognostic value in metastatic breast cancer Clin Cancer Res 12 3337-3343
[4]  
Quackenbush J(2005)Plasma osteopontin levels in multiple sclerosis J Neuroimmunol 158 231-239
[5]  
Chambers AF(2004)Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies Clin Cancer Res 10 184-190
[6]  
Szabo M(2003)Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells J Biol Chem 278 28593-28606
[7]  
Cantor A(2001)Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer Clin Cancer Res 7 4060-4066
[8]  
Coppola D(2001)The functional and clinical roles of osteopontin in cancer and metastasis Curr Mol Med 1 621-632
[9]  
Yeatman TJ(2006)Uses and abuses of tumor markers in the diagnosis, monitoring, and treatment of primary and metastatic breast cancer Oncologist 11 541-552
[10]  
Ang C(2003)Osteopontin overproduced by tumor cells acts as a potent angiogenic factor contributing to tumor growth Cancer Lett 198 107-117